On this page
VA distinguishes a temporary episode of pink eye from chronic conjunctivitis. Under current 38 CFR § 4.79, DC 6018 covers chronic nontrachomatous conjunctivitis. Active disease is evaluated under the General Rating Formula for Diseases of the Eye with a 10-percent minimum. Inactive disease is evaluated from residuals such as visual impairment or disfigurement.
That active-versus-inactive distinction is the center of the claim. Redness or discharge years ago is not the same as objective active disease at the current examination, and recurring treatment is not automatically an “incapacitating episode” under VA's definition.
TL;DR
- DC 6018 covers chronic nontrachomatous conjunctivitis, including chronic allergic conjunctivitis.
- Active chronic conjunctivitis is rated under the eye formula with a minimum 10 percent.
- The eye formula permits a higher evaluation based on visual impairment or qualifying treatment visits when the criteria are met.
- Inactive conjunctivitis is rated from residual visual impairment or disfigurement under DC 7800.
- A qualifying incapacitating episode means an eye condition severe enough to require a clinic visit specifically for treatment. Self-treatment at home is not a qualifying visit.
- Trachomatous conjunctivitis uses DC 6017 and has a different 30-percent active minimum.
- Chronic allergic conjunctivitis may be claimed directly or as secondary to service-connected allergic rhinitis, but the medical link must be documented.
- Across 404 decided Board rulings on chronic conjunctivitis from 2021 to 2026, 23.5% were granted, 31.4% denied and 45.0% remanded. A ruling is one issue the Board decided in one decision; one decision often rules on several issues.
Conjunctivitis VA rating criteria (DC 6018)
Active chronic conjunctivitis
When DC 6018 is active, VA applies the General Rating Formula for Diseases of the Eye and assigns at least 10 percent. Objective findings can include redness, discharge, swelling or other inflammation an eye clinician documents. The exact findings depend on whether the cause is allergic, infectious, irritant, or another chronic process.
The general formula uses whichever produces the higher evaluation: visual impairment caused by the condition or documented incapacitating episodes.
Treatment-visit ladder
The formula counts qualifying incapacitating episodes during the prior 12 months.
- 10%: at least 1 but fewer than 3 treatment visits.
- 20%: at least 3 but fewer than 5 visits.
- 40%: at least 5 but fewer than 7 visits.
- 60%: 7 or more visits.
VA defines an incapacitating episode as an eye condition severe enough to require a clinic visit specifically for treatment. Routine monitoring, a phone message, or buying over-the-counter drops does not automatically satisfy that definition. The record should identify each visit and what treatment was performed.
At the 2026 rates for a single veteran with no dependents, 10 percent pays $180.42 a month, 20 percent $356.66, 40 percent $795.84 and 60 percent $1,435.02.
Inactive disease
When the conjunctivitis is inactive, DC 6018 directs VA to rate residuals such as visual impairment or disfigurement. The examiner should identify whether reduced acuity, field loss, scarring, eyelid change, or another residual is actually attributable to the service-connected conjunctivitis.
Allergic conjunctivitis, blepharitis and other red-eye conditions
Allergic conjunctivitis. Chronic allergic conjunctivitis is rated under DC 6018 like any other chronic nontrachomatous conjunctivitis, so the 10 percent minimum applies while it is active. Itching is its most consistent sign (PMID 24150468), and the record should show the diagnosis, the active findings and every clinic visit for treatment.
Blepharitis. Blepharitis is inflammation of the eyelid margins (PMID 38350160), and the schedule has no code for it. VA rates it by analogy under 38 CFR § 4.20 (opens in a new tab) to the closest listed condition. In Board decisions I reviewed, that was DC 6018 or DC 6025 (lacrimal disorders, 10 percent for one eye and 20 percent for both), depending on whether the symptoms looked more like conjunctivitis or a tearing problem. When blepharitis is part of the same service-connected eye disability as conjunctivitis or dry eye, the Board has treated it as a symptom of that disability rather than rating it separately, because 38 CFR § 4.14 bars rating the same symptoms twice.
Other red-eye conditions. Conjunctivitis affects the conjunctiva. Several other conditions can cause redness, irritation, light sensitivity, or tearing, and each follows a different rating path.
- dry eye syndrome, rated by analogy;
- keratitis and other corneal disease (keratopathy, DC 6001);
- uveitis, rated with other inflammation inside the eye under DC 6000;
- glaucoma, DC 6012 or DC 6013; and
- refractive error, which § 4.75(a) leaves out of visual impairment.
The diagnosis an eye clinician records decides which code applies, so make sure the record names the actual condition rather than "red eye."
How to prove conjunctivitis is service connected
Direct onset or exposure
Direct service connection under 38 CFR § 3.303 requires chronic current disease, an in-service onset or event, and a link between them. Service records showing repeated eye treatment are stronger than a single resolved infection. Environmental irritants may support the history, but exposure alone does not prove that the present condition is the same chronic disease.
Secondary to allergic rhinitis
Allergic conjunctivitis and allergic rhinitis often occur together as allergic rhinoconjunctivitis, one of the most common allergic disorders (PMID 15878455). A secondary claim under § 3.310 should include the service-connected rhinitis record, the current eye diagnosis, and a clinician's explanation that rhinitis caused the chronic eye condition or aggravated it, meaning the eye condition would be less severe but for the rhinitis.
Medication effects, autoimmune disease, and other service-connected conditions may create other secondary theories. The opinion should identify the mechanism instead of relying on a list of possible associations.
The conjunctivitis C&P exam
Under § 4.75(b), the eye exam must be done by a licensed optometrist or ophthalmologist. Bring, or make sure the file already holds, these records.
- Eye-clinic diagnoses and slit-lamp findings.
- Photographs from active flares when the exam occurs on a clear day.
- The date and purpose of every treatment visit in the prior 12 months.
- Prescription drops, systemic treatment, procedures, and response.
- Corrected visual acuity and any visual-field testing when medically indicated.
- Residual scarring or disfigurement after the active inflammation ends.
- The frequency and duration of recurrences.
VA rates the disability shown in the record. A symptom diary is helpful context, but clinician observations and treatment records establish whether disease is active and whether visits satisfy the formula.
Why VA denies conjunctivitis claims
Across 404 decided Board rulings on chronic conjunctivitis from 2021 to 2026, 23.5% were granted, 31.4% denied and 45.0% remanded. That grant rate is 1.3 percentage points below the 24.7 percent across all decided Board rulings, and remand is the most common outcome. When the Board sent these claims back, the most common reason was a VA exam or opinion that was not adequate; the Board section below shows why claims were sent back and how service connection appeals compared with appeals for a higher rating. The same mistakes repeat.
- Filing a one-time acute infection as chronic conjunctivitis without current disease. Most uncomplicated bacterial conjunctivitis clears in one to two weeks (PMID 24150468).
- Calling every urgent-care or monitoring contact an incapacitating episode.
- Using DC 6017's 30-percent trachoma minimum for ordinary nontrachomatous conjunctivitis.
- Attributing reduced vision to conjunctivitis without an eye examiner making that connection.
- Missing active flares because no photographs or interval treatment records were submitted.
Questions veterans ask about conjunctivitis
What is the VA rating for chronic conjunctivitis?
Active chronic conjunctivitis rates at least 10 percent under DC 6018. It can rate 20, 40 or 60 percent with 3, 5 or 7 treatment visits in the past 12 months, or higher on visual impairment if that is greater, while inactive disease is rated only on lasting residuals.
What is the VA rating for allergic conjunctivitis?
Chronic allergic conjunctivitis is rated the same way, under DC 6018, with a 10 percent minimum while it is active. A seasonal flare that resolves without lasting disease is harder to rate, so the record should show recurring, clinician-documented activity.
How does VA rate blepharitis?
VA rates blepharitis by analogy because it has no code of its own, most often under DC 6018 for chronic conjunctivitis or DC 6025 for lacrimal disorders. If blepharitis is part of an eye disability already rated under DC 6018, it is usually treated as one of its symptoms.
Is pink eye a VA disability?
A single episode of pink eye that cleared up is not a ratable disability. VA needs chronic conjunctivitis that is present now and linked to service.
Can conjunctivitis be secondary to allergic rhinitis?
Yes, if a clinician explains how the service-connected rhinitis caused the eye condition or made it worse. Allergic rhinitis and allergic conjunctivitis often occur together, but the opinion still has to connect them in your records.
Bottom Line
DC 6018 gives active chronic conjunctivitis a 10-percent minimum, but higher evaluations require actual visual impairment or the defined number of treatment visits. Inactive disease is rated from lasting residuals. The strongest packet proves the diagnosis, captures objective active findings, and separates conjunctivitis from dry eye and more serious eye disease.
Methodology and Limitations
- Data source: 38 CFR § 4.79 (opens in a new tab) (DCs 6000, 6001, 6017, 6018 and 6025 and the General Rating Formula for Diseases of the Eye), §§ 4.14, 4.20 and 4.75, § 3.303 (opens in a new tab) and § 3.310 (opens in a new tab), checked against the eCFR text in October 2026. The blepharitis and allergic conjunctivitis rating practice comes from 2025 Board decisions (citations A25005592, A25007179 and 25008292). Medical background from PubMed abstracts (PMIDs 24150468, 38350160 and 15878455).
- Sample size: Board figures come from Claim Raven's read of 510,968 Board decisions from 2021 to 2026, which contain 1,376,193 rulings, including 454 rulings on chronic conjunctivitis. The Board section on this page breaks these down by remand reason, appeal type and era; those figures are computed from the data, not typed here.
- Limitations: Pay figures are the 2026 rates (effective December 1, 2025) for a single veteran with no dependents. BVA-level patterns reflect cases that appealed and are not predictions of individual outcomes.
